Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Disease Activity
Email alerts
Disease Activity
Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Jian
Tian
,
Chao
Cheng
,
Fangjie
Zhang
Annals of the Rheumatic Diseases
Sep 2020,
79
(9)
e112;
DOI:
10.1136/annrheumdis-2019-215745
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian
et al
Vinod
Chandran
,
Richard J
Cook
,
Dafna D
Gladman
Annals of the Rheumatic Diseases
Sep 2020,
79
(9)
e113;
DOI:
10.1136/annrheumdis-2019-215762
Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra
et al
Antonis
Fanouriakis
,
George K
Bertsias
,
Dimitrios T
Boumpas
Annals of the Rheumatic Diseases
Sep 2020,
79
(9)
e115;
DOI:
10.1136/annrheumdis-2019-215746
SLE-DAS: ready for routine use?
Anoop
Mathew
,
Kavadichanda G
Chengappa
,
Sanket
Shah
,
Vir Singh
Negi
Annals of the Rheumatic Diseases
Sep 2020,
79
(9)
e116;
DOI:
10.1136/annrheumdis-2019-215704
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study
Paul
Emery
,
Gerd R
Burmester
,
Esperanza
Naredo
,
Luigi
Sinigaglia
,
Ivan
Lagunes
,
Franziska
Koenigsbauer
,
Philip G
Conaghan
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
1023-1030;
DOI:
10.1136/annrheumdis-2020-217246
Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Claudia
Kedor
,
Joachim
Listing
,
Jan
Zernicke
,
Anja
Weiß
,
Frank
Behrens
,
Norbert
Blank
,
Joerg Christoph
Henes
,
Joern
Kekow
,
Andrea
Rubbert-Roth
,
Hendrik
Schulze-Koops
,
Eva
Seipelt
,
Christof
Specker
,
Eugen
Feist
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
1090-1097;
DOI:
10.1136/annrheumdis-2020-217155
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones
et al’
by Vandergheynst
et al
Rachel B
Jones
,
Thomas F
Hiemstra
,
Michael
Walsh
,
David
Jayne
,
Lorraine
Harper
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
e101;
DOI:
10.1136/annrheumdis-2019-215658
Response to ‘Decision making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?’ by Deng
et al
Luis Eduardo Coelho
Andrade
,
Jan
Damoiseaux
,
Edward K
Chan
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
e93;
DOI:
10.1136/annrheumdis-2019-215640
Differentiating disease activity from damage in systemic sclerosis: it’s still early days!
Siddharth
Jain
,
Shefali Khanna
Sharma
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
e98;
DOI:
10.1136/annrheumdis-2019-215588
Response to: ‘Differentiating disease activity from damage in systemic sclerosis: it’s still early days!’ by Jain and Sharma
Mandana
Nikpour
Annals of the Rheumatic Diseases
Aug 2020,
79
(8)
e99;
DOI:
10.1136/annrheumdis-2019-215639
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)